DHL Group plans to spend ... $5 billion in global revenue in 2024. Investment in the health care sector — including medical device, clinical trial, biopharma, cell and gene therapy logistics ...

Shipping and logistics giant DHL Group is earmarking 2 billion euros ($2.2 billion) to bulk up its healthcare supply chain ...

DHL said a major new investment will help double revenue for health care logistics by 2030 while FedEx says its technology ...

The investment will focus on enhancing infrastructure and technology across all logistics touchpoints, creating resilient, ...

Investment to address growing demand in pharmaceuticals, medical devices and fast growing areas like clinical trials.

Investment to address growing customer demand in pharmaceuticals, medical devices, and fast-growing areas like clinical ...

DHL Group has established a DHL Health Logistics brand and announced a €2bn investment into its logistics capabilities in the ...

DHL Group to invest US$2.2bn in healthcare logistics - read more about this with Parcel and Postal Technology International ...

DHL Group has announced a €2 billion strategic investment over the next five years to enhance its logistics operations in the life sciences and ...

CRYOPDP is a leading specialty courier providing services for clinical trials, biopharma, and cell & gene therapies.

DHL to acquire 100% of CRYOPDP, a leading specialty courier providing logistics services for clinical trials, biopharma, and cell & gene therapies. This acquisition enhances DHL's capabilities in ...